{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T14:39:43Z","timestamp":1783175983904,"version":"3.54.6"},"reference-count":33,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.contraception.2012.05.023","type":"journal-article","created":{"date-parts":[[2012,7,7]],"date-time":"2012-07-07T00:49:49Z","timestamp":1341622189000},"page":"746-751","source":"Crossref","is-referenced-by-count":18,"title":["Trends in use of medical abortion in the United States: reanalysis of surveillance data from the Centers for Disease Control and Prevention, 2001\u20132008"],"prefix":"10.1016","volume":"86","author":[{"given":"Karen","family":"Pazol","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreea A.","family":"Creanga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne B.","family":"Zane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2012.05.023_bb0005","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.contraception.2010.05.017","article-title":"Happy anniversary mifepristone: a decade of promise and challenges","volume":"82","author":"Jordan","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.05.023_bb0010","first-page":"4","article-title":"Mifepristone in the United States: status and future","volume":"5","author":"Boonstra","year":"2002","journal-title":"Guttmacher Rep Public Policy"},{"key":"10.1016\/j.contraception.2012.05.023_bb0015","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1097\/AOG.0b013e3181b2a74d","article-title":"Effect of mifepristone on abortion access in the United States","volume":"114","author":"Finer","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2012.05.023_bb0020","first-page":"1","article-title":"Abortion surveillance \u2014 United States, 2008","volume":"60","author":"Pazol","year":"2011","journal-title":"MMWR Surveill Summ"},{"key":"10.1016\/j.contraception.2012.05.023_bb0025","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1363\/4304111","article-title":"Abortion incidence and access to services in the United States, 2008","volume":"43","author":"Jones","year":"2011","journal-title":"Perspect Sex Reprod Health"},{"key":"10.1016\/j.contraception.2012.05.023_bb0030","author":"Guttmacher Institute"},{"key":"10.1016\/j.contraception.2012.05.023_bb0035","doi-asserted-by":"crossref","first-page":"244","DOI":"10.2307\/2991612","article-title":"Abortion reporting in the United States: an examination of the federal-state partnership","volume":"30","author":"Saul","year":"1998","journal-title":"Fam Plann Perspect"},{"key":"10.1016\/j.contraception.2012.05.023_bb0040","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1363\/4321811","article-title":"Medication abortions among New York City residents, 2001\u20132008","volume":"43","author":"Yunzal-Butler","year":"2011","journal-title":"Perspect Sex Reprod Health"},{"key":"10.1016\/j.contraception.2012.05.023_bb0045","series-title":"Estimated pregnancy rates by outcome for the United States, 1990\u20132004","author":"Ventura","year":"2008"},{"key":"10.1016\/j.contraception.2012.05.023_bb0050","doi-asserted-by":"crossref","unstructured":"Henshaw SK, Van Vort J. Abortion services in the United States, 1991 and 1992. Fam Plann Perspect 1994;26:100\u20136, 12.","DOI":"10.2307\/2136033"},{"key":"10.1016\/j.contraception.2012.05.023_bb0055","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.contraception.2010.08.009","article-title":"Introduction and provision of medical abortion: a tale of two countries in which technology is necessary but not sufficient","volume":"83","author":"Winikoff","year":"2011","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.05.023_bb0060","first-page":"871","article-title":"ACOG practice bulletin: clinical management guidelines for obstetrician\u2013gynecologists","volume":"106","author":"ACOG Committee","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2012.05.023_bb0065","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1363\/4000608","article-title":"Abortion in the United States: incidence and access to services, 2005","volume":"40","author":"Jones","year":"2008","journal-title":"Perspect Sex Reprod Health"},{"key":"10.1016\/j.contraception.2012.05.023_bb0070","doi-asserted-by":"crossref","first-page":"154","DOI":"10.2307\/3097714","article-title":"Mifepristone for early medical abortion: experiences in France, Great Britain and Sweden","volume":"34","author":"Jones","year":"2002","journal-title":"Perspect Sex Reprod Health"},{"key":"10.1016\/j.contraception.2012.05.023_bb0075","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ajog.2008.11.016","article-title":"Recent advances in second-trimester abortion: an evidence-based review","volume":"200","author":"Hammond","year":"2009","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2012.05.023_bb0080","series-title":"Management of unintended and abnormal pregnancy: comprehensive abortion care","first-page":"178","article-title":"Medical methods to induce abortion in the second trimester","author":"Kapp","year":"2009"},{"key":"10.1016\/j.contraception.2012.05.023_bb0085","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.contraception.2011.02.005","article-title":"Clinical guidelines. Labor induction abortion in the second trimester","volume":"84","author":"Borgatta","year":"2011","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.05.023_bb0090","author":"Guttmacher Institute"},{"key":"10.1016\/j.contraception.2012.05.023_bb0095","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1056\/NEJMp1109889","article-title":"The supply-side economics of abortion","volume":"365","author":"Joyce","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.contraception.2012.05.023_bb0100","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.2105\/AJPH.2008.136325","article-title":"Medical liability insurance as a barrier to the provision of abortion services in family medicine","volume":"98","author":"Dehlendorf","year":"2008","journal-title":"Am J Public Health"},{"key":"10.1016\/j.contraception.2012.05.023_bb0105","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/AOG.0b013e318224d110","article-title":"Effectiveness and acceptability of medical abortion provided through telemedicine","volume":"118","author":"Grossman","year":"2011","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2012.05.023_bb0110","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0968-8080(09)33445-X","article-title":"Non-physician clinicians can safely provide first trimester medical abortion","volume":"17","author":"Yarnall","year":"2009","journal-title":"Reprod Health Matters"},{"key":"10.1016\/j.contraception.2012.05.023_bb0115","author":"Guttmacher Institute"},{"key":"10.1016\/j.contraception.2012.05.023_bb0120","series-title":"Management of unintended and abnormal pregnancy: comprehensive abortion care","first-page":"111","article-title":"Medical abortion early in pregnancy","author":"Creinin","year":"2009"},{"key":"10.1016\/j.contraception.2012.05.023_bb0125","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.contraception.2010.09.002","article-title":"Comparing two early medical abortion regimens: mifepristone+misoprostol vs. misoprostol alone","volume":"83","author":"Ngoc","year":"2011","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.05.023_bb0130","first-page":"1","article-title":"Abortion surveillance \u2014 United States, 2000","volume":"52","author":"Elam-Evans","year":"2003","journal-title":"MMWR Surveill Summ"},{"key":"10.1016\/j.contraception.2012.05.023_bb0135","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1363\/3501603","article-title":"The accessibility of abortion services in the United States, 2001","volume":"35","author":"Henshaw","year":"2003","journal-title":"Perspect Sex Reprod Health"},{"key":"10.1016\/j.contraception.2012.05.023_bb0140","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3109\/13625187.2011.555568","article-title":"Mifepristone followed by home administration of buccal misoprostol for medical abortion up to 70 days of amenorrhoea in a general practice in Curacao","volume":"16","author":"Boersma","year":"2011","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2012.05.023_bb0145","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1097\/01.AOG.0000259319.18958.76","article-title":"Mifepristone followed in 24 hours to 48 hours by misoprostol for late first-trimester abortion","volume":"109","author":"Bracken","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2012.05.023_bb0150","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ejogrb.2005.11.001","article-title":"Consistency of medical abortion efficacy from 5 through 14 weeks' gestation","volume":"129","author":"Garbin","year":"2006","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.contraception.2012.05.023_bb0155","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1111\/j.1471-0528.2005.00638.x","article-title":"A randomised controlled trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion up to 13 weeks of gestation","volume":"112","author":"Hamoda","year":"2005","journal-title":"BJOG"},{"key":"10.1016\/j.contraception.2012.05.023_bb0160","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.contraception.2004.10.015","article-title":"Medical abortion at 9\u201313 weeks' gestation: a review of 1076 consecutive cases","volume":"71","author":"Hamoda","year":"2005","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.05.023_bb0165","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1097\/AOG.0b013e3181da0c3e","article-title":"Medical abortion at 63 to 90 days of gestation","volume":"115","author":"Lokeland","year":"2010","journal-title":"Obstet Gynecol"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782412002880?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782412002880?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,30]],"date-time":"2019-06-30T13:25:55Z","timestamp":1561901155000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782412002880"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S0010782412002880"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2012.05.023","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}